Chemosensitization and drug accumulation assays as complementary methods for the screening of multidrug resistance reversal agents
- 19 January 1996
- journal article
- research article
- Published by Elsevier BV in Cancer Letters
- Vol. 99 (1), 109-114
- https://doi.org/10.1016/0304-3835(95)04044-7
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Influence of dexniguldipine-HCl on rhodamine-123 accumulation in a multidrug-resistant leukaemia cell line: Comparison with other chemosensitisersEuropean Journal Of Cancer, 1994
- Multidrug resistance in cancer chemotherapyInvestigational New Drugs, 1994
- BIOCHEMISTRY OF MULTIDRUG RESISTANCE MEDIATED BY THE MULTIDRUG TRANSPORTERAnnual Review of Biochemistry, 1993
- SDZ PSC 833 and SDZ 280–446 are the most active of various resistance-modifying agents in restoring rhodamine-123 retention within multidrug resistant P388 cellsAnti-Cancer Drugs, 1992
- SDZ 280-446, a novel semi-synthetic cyclopeptolide: in vitro and in vivo circumvention of the P-glycoprotein-mediated tumour cell multidrug resistanceBritish Journal of Cancer, 1992
- Modulation of antitumour drug resistance: experimental laboratory data and results of clinical evaluationCancer Treatment Reviews, 1990
- Use of fluorescent dyes as molecular probes for the study of multidrug resistanceExperimental Cell Research, 1987
- Isolation and characterization of a human colon adenocarcinoma cell line resistant to doxorubicinBritish Journal of Cancer, 1986
- Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assaysJournal of Immunological Methods, 1983
- Monitoring of relative mitochondrial membrane potential in living cells by fluorescence microscopy.The Journal of cell biology, 1981